Legislative and Regulatory Issues of Interest

AACE Submits Comments on Therapeutic Options for Obesity in the Medicare Population

Click here to read the article.



AACE Supports Concept of Bill That Eliminates Disparities in Diabetes

AACE has sent a letter to Representative Diana DeGette (D-1st-CO) in support of the concept of H.R. 3322, the Eliminating Disparities in Diabetes Prevention, Access and Care Act, but noting that the National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539) would address those disparities.



AACE Urges HHS To Act On Medicare Appeals Backlog

AACE has joined the AMA and other state and medical specialty societies to urge the HHS Office of Medicare Hearings and Appeals (OMHA) to develop a comprehensive solution to the backlog of claims in the Medicare appeals process following a recently issued notice that assignment of requests for Administrative Law Judge hearings may be delayed for 28 months.



AACE Urges Congress to Eliminate the SGR Formula

AACE has joined the AMA and other organizations in congratulating the House and Senate on introducing the “SGR Repeal and Medicare Provider Payment Modernization Act of 2014” (H.R. 4015/ S. 2000) and urged them to seize this opportunity to eliminate the SGR formula.



AACE Submits Comments on the 2014 Medicare Physician Fee Schedule Final Rule

AACE submitted a comment letter to the Centers for Medicare and Medicaid Services on the final rule of the Medicare physician payment policy for calendar year 2014.



AACE Comments to Leadership on SGR Repeal

AACE, as a member of the Cognitive Specialty Coalition, sent a letter to the leadership of the Senate Finance Committee and the House Ways and Means Committee commenting on repealing the Sustainable Growth Rate (SGR) formula and urging a vote to advance the legislation.



AACE Comments on FDA Hearing for Dapagliflozin

AACE provided comments for the FDA Endocrinologic and Metabolic Drug Advisory Committee hearing on the new drug application for Farxiga (dapagliflozin). While not advocating for the individual drug, the letter was in support of SGLT2 inhibitors as a treatment for type 2 diabetes.



AACE Comments on SGR Repeal and Medicare Physician Payment Reform Proposal

AACE sent a comment letter to the leadership of the Senate Finance Committee and the House Ways and Means Committee on the Sustainable Growth Rate (SGR) repeal and Medicare physician payment reform proposal.



Congress Urged to Hold Hearing on Diabetes

AACE, as a member of the Diabetes Advocacy Alliance (DAA), sent a letter to Senate and House leaders urging that a hearing be held to address the growing diabetes epidemic in America.



AACE Urges VHA to Revise Draft VHA Nursing Handbook

AACE, along with the AMA and other organizations, sent a letter of concern to the Undersecretary for Veterans Health Affairs (VHA) regarding a mandate in their draft Nursing Handbook that all advanced practice nurses within the VHA be designated as independent providers, which will eliminate physician-led, team-based care within the VHA system.



AACE Comments on the HHS Strategic Plan for 2014-2018

AACE, as a member of the Diabetes Advocacy Alliance (DAA), provided comments to HHS Secretary Kathleen Sebelius on the four goals of the Strategic Plan for 2014-2018 in relation to improving diabetes prevention, detection and care.



AACE Supports Continuing Certification Requirements for Bariatric Surgery Facilities

AACE sent a letter to the Centers for Medicare and Medicaid Services opposing the decision to eliminate the Centers of Excellence certification requirements for bariatric surgery centers.



AACE Submits Comments on the 2014 Medicare Physician Fee Schedule Proposed Rule

AACE submitted a comment letter to the Centers for Medicare and Medicaid Services on the proposed changes in the Medicare physician payment policy for calendar year 2014.



AACE Opposes Payment Cap on Certain Physician Services at Lower Hospital Outpatient or ASC Facility Setting Rates

AACE joined the AMA and several medical societies in sending a letter to CMS on a specific provision contained in the 2014 Medicare Physician Fee Schedule proposed rule that would cap payment for 211 identified services provided in a physician’s office when payment for those services is greater than what is paid either in the hospital outpatient or ambulatory surgical center facility setting.



AACE Comments on Bioequivalent Study Design Recommendations for Multiple Drugs

AACE presented comments to the Food and Drug Administration (FDA) regarding the bioequivalence study design reccomendations for the drugs methyltestosterone, colesevelam hydrochloride, phentermine hydrochloride; topiramate, and medroxyprogesterone acetate.



Letter of Support Sent to Sponsors of Gestational Diabetes Act

AACE, as a member of the Diabetes Advocacy Alliance (DAA), sent a letter of support to the House and Senate sponsors for the Gestational Diabetes Act (H.R. 1915/S. 907).



AACE Responds to House E&C Questions on SGR

AACE responded to a solicitation by the House Energy and Commerce Committee to provide comments on specific questions in regards to developing legislation that repeals the Medicare Sustainable Growth Rate (SGR) formula.



AACE Responds To Solicitation for Comment on the Medicare Physician Fee Schedule

AACE responded to a solicitation by the Senate Finance Committee to provide input on policies related to the Medicare physician fee schedule.



AACE Supports Bill To Prohibit ICD-10 Implementation

AACE has sent a letter to Representative Ted Poe (R-2nd-TX) in support of H.R. 1701, the Cutting Costly Codes Act of 2013, which prohibits HHS from replacing the current ICD-9 code set with the ICD-10 code set.



Letter Sent to Congress in Support of the Medicare Diabetes Prevention Act of 2013

AACE has joined the AMA and other organizations in sending a letter to Members of Congress supporting the Medicare Diabetes Prevention Act of 2013, which provides coverage for the National Diabetes Prevention Program under the Medicare program.



Letter of Support to Rep. Tom Price for H.R. 1310

AACE, along with the AMA and other medical societies, sent a letter of support to Rep. Tom Price (R-6th-GA) for introducing H.R. 1310, the “Medicare Patient Empowerment Act”, which ensures that Medicare beneficiaries and physicians are able to freely contract for covered Medicare services without penalty, while at the same time providing important beneficiary protections.



Letter of Support Sent to Sponsors of Access to Quality Diabetes Education Act of 2013

AACE, as a member of the Diabetes Advocacy Alliance (DAA), sent a letter of support to the House Diabetes Caucus co-chairs for introducing H.R. 1274, the Access to Quality Diabetes Education Act of 2013, which provides older diabetic adults with the opportunity to better manage their disease through self-management.



Letter of Support Sent to Sponsor of the Preventing Diabetes in Medicare Act of 2013

AACE, as a member of the Diabetes Advocacy Alliance (DAA), sent a letter of support to Representative Diana DeGette (D-1st-CO) for introducing H.R. 1257, the Preventing Diabetes in Medicare Act of 2013, which would extend Medicare coverage of medical nutrition therapy services to people with prediabetes and other risk factors for developing type 2 diabetes.



Letter of Support Sent to Sponsors of H.R. 1074 / S. 539

AACE, as a member of the Diabetes Advocacy Alliance (DAA), sent a letter of support to the House and Senate sponsors of the National Diabetes Clinical Care Commission Act (H.R. 1074 / S. 539).



Letter of Support Sent to Sponsors of the Medicare Diabetes Prevention Act of 2013

AACE, as a member of the Diabetes Advocacy Alliance (DAA), sent a letter of support to the House and Senate sponsors of the Medicare Diabetes Prevention Act of 2013, which provides coverage of diabetes prevention program services for older adults at high risk for type 2 diabetes.



Letter to FDA Regarding a New Drug Approval Pathway

AACE presented comments to the Food and Drug Administration (FDA) regarding the bioequivalence study design reccomendations for the drugs methyltestosterone, colesevelam hydrochloride, phentermine hydrochloride; topiramate, and medroxyprogesterone acetate.



AACE Comments to FDA on Bioequivalent Study Design Recommendations for Liothyronine Sodium

AACE commented on proposed study recommendations from the Food and Drug Administration (FDA) to drug and device manufacturers regarding bioequivalence studies of liothyronine sodium.



Letter to FDA on Cancer Risks Associated with Calcitonin Salmon

AACE provided comments to the Food and Drug Administration discussing whether the benefit of calcitonin salmon for treatment of postmenopausal osteoporosis outweighs a potential risk of cancer.



Letters of Support Sent to Sponsors of Protecting Seniors’ Access to Medicare Act of 2013

AACE, as a member of the Independent Payment Advisory Board (IPAB) Coalition, sent letters of support to Sen. John Cornyn (R-TX) and Rep. Phil Roe (R-1st-TN) for introducing the Protecting Seniors’ Access to Medicare Act of 2013, which repeals the IPAB.



AACE Comments on the USPSTF’s Future Update to Diabetes Screening Recommendations

AACE, as a member of the Diabetes Advocacy Alliance (DAA), sent a comment letter to the US Preventive Services Task Force (USPSTF) containing recommendations for the future update to diabetes screening for Type 2 Diabetes Mellitus in adults.



AACE
Guidelines

AACE Clinical Practice Guidelines are systematically developed, evidence-based documents that assist practitioners about appropriate health care decisions

AACE Position Statements

AACE's Position Statements meet rigorous criteria before being published and utilized and serve as one of the worlds' most trusted sources

AACE
Publications

AACE continually strives to bring to the world definitive protocols, guidelines and discoveries which further and enhance the greater medical health of the general public.

Find an Endocrinologist

Find an Endocrinologist in your area by entering a ZIP code, or your city and state using our search feature.